<SEC-DOCUMENT>0001193125-21-038762-index.html : 20210211 <SEC-HEADER>0001193125-21-038762.hdr.sgml : 20210211 <ACCEPTANCE-DATETIME>20210211171833 ACCESSION NUMBER: 0001193125-21-038762 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 7 CONFORMED PERIOD OF REPORT: 20210211 FILED AS OF DATE: 20210211 DATE AS OF CHANGE: 20210211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Autolus Therapeutics plc CENTRAL INDEX KEY: 0001730463 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38547 FILM NUMBER: 21620978 BUSINESS ADDRESS: STREET 1: FOREST HOUSE, 58 WOOD LANE STREET 2: WHITE CITY CITY: LONDON STATE: X0 ZIP: W12 7RZ BUSINESS PHONE: 44 20 3829 6230 MAIL ADDRESS: STREET 1: FOREST HOUSE, 58 WOOD LANE STREET 2: WHITE CITY CITY: LONDON STATE: X0 ZIP: W12 7RZ FORMER COMPANY: FORMER CONFORMED NAME: Autolus Therapeutics Ltd DATE OF NAME CHANGE: 20180205 </SEC-HEADER> <DOCUMENT> <TYPE>6-K <SEQUENCE>1 <FILENAME>d101063d6k.htm <DESCRIPTION>6-K <TEXT> Document 1 - file: d101063d6k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1.1 <SEQUENCE>2 <FILENAME>d101063dex11.htm <DESCRIPTION>EX-1.1 <TEXT> Document 2 - file: d101063dex11.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>3 <FILENAME>d101063dex51.htm <DESCRIPTION>EX-5.1 <TEXT> Document 3 - file: d101063dex51.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>4 <FILENAME>d101063dex991.htm <DESCRIPTION>EX-99.1 <TEXT> Document 4 - file: d101063dex991.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>5 <FILENAME>d101063dex992.htm <DESCRIPTION>EX-99.2 <TEXT> Document 5 - file: d101063dex992.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>g101063g42a13.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: g101063g42a13.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>g101063g64m74.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 7 - file: g101063g64m74.jpg
</DOCUMENT> </SEC-DOCUMENT>